Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
ROCKVILLE, Maryland, August 26 /PRNewswire/ --
- VLP Vaccine - Coupled with Innovative Manufacturing - Has Potential to Address Gaps in Global Pandemic Preparedness
Novavax, Inc. (Nasdaq: NVAX)…